Department of Medicine Faculty
Bio
Administrator Info
Name: DHM Admin Team
Email: dhmadmin@umn.edu
Phone Number: 612-624-0579
Fax Number: 612-624-3189
Summary
Dr. Matthew Diehl is joining the Academic Hospitalist team with a focus and clinical interest in collaborative teaching, standardization of documentation and care guidelines. He also has an interest in Space Medicine.
Research Summary
Medical Education
Teaching Summary
Global Health
Bio
Administrator Info
Name: DHM Admin Team
Email: dhmadmin@umn.edu
Phone Number: 612-624-0579
Fax Number: 612-624-3189
Summary
Dr. Dimitrov is an Assistant Professor of Medicine at the University of Minnesota Medical School. His academic interests include medical education and bedside ultrasonography/medical technology. Dr. Dimitrov's clinical and teaching interests involve hospital medicine, healthcare advocacy, and evidence-based medicine.
Research Summary
Medical Education
Teaching Summary
Hospital Medicine; Bedside Ultrasonography; Diagnostic Reasoning; Epidemiology
Clinical Summary
Hospital Medicine; Healthcare Advocacy; Bedside Ultrasonography; Evidence-Based Medicine
Bio
Administrator Info
Name: Abigail Alves
Phone: 612-624-0999
Email: aalves@umn.edu
Fax: 612-625-2174
Summary
Dr. Dincer is the PACCS Division Director, Chief of the Medical Subspecialty Service Line, Vice Chair of Clinical Affairs at the Department of Medicine and the Director of Interventional Pulmonary Program at M Health Fairview. After joining the UMN faculty in 2011, he developed the Lung Nodule Program and, one year later, the multidisciplinary IP program in collaboration with Thoracic Surgery, Interventional Radiology, and Medical Oncology. Dr. Dincer holds an MD from Istanbul University where he also finished a 4-year Internal Medicine Residency. He completed an Internal Medicine Residency with a research year working on alveolar epithelial cell apoptosis as a pathway to interstitial lung diseases at UIC/Michael Reese Hospital in Chicago. After a year of chief residency at the Michael Reese Hospital, he completed a fellowship in Pulmonary & Critical Care Medicine at the Medical College of Wisconsin in Milwaukee. He also holds an executive Masters in Healthcare Administration from the UMN School of Public Health. Dr. Dincer is a nationally and internationally recognized expert in minimally invasive procedures in diagnosing and treating lung diseases and is board certified in Internal Medicine, Pulmonary Medicine, Critical Care Medicine and Sleep Medicine.
Clinical Summary
Complex airway diseases (tumor debulking with various methods, balloon bronchoplasty, stent placement, intrabronchial valve placement, bronchoscopic lung volume reduction, treatment of tracheal or airway stenosis); Bronchial Thermoplasty for uncontrolled severe asthma; Lung transplant airway complications; Cryoprobe lung biopsy in ILD, ARDS and diffuse parenchymal lung diseases; Medical thoracoscopy for undiagnosed pleural effusions; Intrabronchial valve placement for prolonged air leaks; Naviga
Honors and Recognition
Bio
Administrator Info
Name: Nephrology
Phone: 612-624-9444
Email: renaldiv@umn.edu
Fax: 612-626-3840
Summary
Dr. Drawz earned his medical degree from the University of Minnesota and completed his Internal Medicine Residency and Nephrology Fellowship at Case Western Reserve University. His research interests include hypertension, ambulatory blood pressure monitoring, and acute kidney injury. He is the recipient of an R01 from NHLBI. Dr. Drawz's clinical interests include hypertension, chronic kidney disease, and inpatient nephrology.
Research Summary
- Hypertension
- Ambulatory Blood Pressure Monitoring
- Acute Kidney Injury
- Health Disparities
Research Projects
- Blood Pressure and Kidney Function - SPRINT vs Electronic Health Record Data (5R01HL136679 from NHLBI)
- Preventing Cognitive Decline by Reducing BP Target Trial (PCOT; 1R61AG068486 from NIA)
- MN EHR Consortium COVID-19 Project
Clinical Summary
- Chronic Kidney Disease
- General Nephrology
- Hypertension
Honors and Recognition
Bio
Administrator Info
Name: Helen Rieger
Phone: 612-624-0999
Email: riege002@umn.edu
Fax: 612-625-2174
Summary
Dr. Dudley's research is focused on measuring clinical performance and using incentives to improve it. Dr. Dudley has applied both qualitative and quantitative methods to identify important policy issues, such as variation in quality of care, and to study first the feasibility of and then the impact of novel policy responses, including payment reform and public reporting of quality of care. In a series of articles spanning the last decade, Dr. Dudley developed methods to identify organizations whose performance could improve and showed that such improvement was possible. His work led both to business leaders such as the Leapfrog Group realizing that they could influence health care in a positive way and to clinicians and policymakers recognizing that care re-engineering in the VA system had already contributed to dramatic improvement. Dr. Dudley also has led important efforts to advance the science of performance measurement. These include both projects creating novel models to risk-adjust outcomes like intensive care unit mortality and length of stay and survey instruments to capture patient assessments of care. These measures are extensively used in ongoing health care, including by the California Hospital Assessment and Reporting Taskforce, a collaborative he founded and in which more than 220 hospitals participate. Dr. Dudley's current work involves randomized controlled trials and observational studies of incentive programs and projects to understand the sources of performance variation among providers, especially as relates to disparities in care.
Bio
Administrator Info
Name: Mayna Xiong
Email: xion2253@umn.edu
Mail: 2231 6th Street SE
4-141 CCRB
Minneapolis, MN 55455
Summary
Prior to his position with the U of MN, he served as Chief of Cardiology at Brown University in Rhode Island. Previously, he served as Chief of Cardiology and co-director of the Center for Cardiovascular Research at the University of Illinois at Chicago.
He received his MD/PhD degrees from the Medical College of Virginia, Virginia Commonwealth University, in Richmond, Virginia. He completed his residency, postdoctoral fellowship and cardiology fellowship at the University of Chicago in Chicago, Illinois. He serves on several editorial boards for publications including the Journal of the American College of Cardiology. Dr. Dudley is a fellow of the American College of Cardiology and the American Heart Association and is a member of the Association of University Cardiologists, the American Society for Clinical Investigation, the Heart Rhythm Society, the Cardiac Electrophysiology Society, and the Cardiac Muscle Society, among others. His research interests include arrhythmias and diastolic heart failure.
Research Summary
- Diastolic heart failure
- Sudden cardiac death
Research Funding Grants
- NIH Grant Number: 1 T32 HL144472-01A1
PI: Crawford, Peter A & Samuel Dudley, M.D., Ph.D. (Contact)
Project Title: Training Program in Cardiac Innovation - NIH RePORTER ID: 1R01HL134791-01A1
PI: Samuel C. Dudley, M.D., Ph.D.
Project Title: Unfolded Protein Response and Arrhythmias - NIH RePORTER ID: 1R01HL136757-01
Sub PI: Samuel C. Dudley, M.D., Ph.D.
Project Title: Regulation of Mitochondrial Calcium Uniporter in the Heart
Clinical Summary
Cardiac arrhythmia, Arrhythmia, Heart failure, Heart failure with preserved ejection fraction
Bio
Administrator Info
Name: DHM Admin Team
Email: dhmadmin@umn.edu
Phone Number: 612-624-0579
Fax Number: 612-624-3189
Summary
Dr. Alec Duffy is an internal medicine and pediatric hospitalist. He attended medical school at New York Medical College and completed his internal medicine and pediatrics residency training at the University of Minnesota.
Research Summary
- Medical Education
Teaching Summary
- Point of Care Ultrasound
Clinical Summary
- Hospital Medicine
- Point of Care Ultrasound
Education
Honors and Recognition
Professional Memberships
Bio
Administrator Info
Name: DHM Admin Team
Email: dhmadmin@umn.edu
Phone Number: 612-624-0579
Fax Number: 612-624-3189
Summary
Dr. Duffy is an Associate Professor of Medicine at the University of Minnesota. She earned her medical degree from the Medical College of Wisconsin and completed her residency in Internal Medicine at the University of Wisconsin. She completed a joint fellowship in General Internal Medicine--Medical Education and Women's Health at the University of Pittsburgh where she also earned her Master's of Science in Medical Education. Dr. Duffy is interested in educating medical students and residents and currently is an instructor in the Essentials of Clinical Medicine course at the Medical School. She is the Internal Medicine Residency Director where she leads the Clinician Educator Pathway. She is board certified in Internal Medicine and practices outpatient medicine in the Primary Care Center and inpatient medicine at the University of Minnesota Medical Center Fairview.
Research Summary
Research Projects
- Herz Faculty Teaching Development Award, University of Minnesota Medical School, Principal Investigator, 7/1/13-6/30/14
- Project DART, iInTIME Educational Scholarship Grant, Co-investigator, 7/1/13-6/30/14
Clinical Summary
- Preventive Medicine
- Hospital Medicine
- Women's Health
- Medical Education
Education
Honors and Recognition
Professional Memberships
Selected Publications
Bio
Administrator Info
Name: Emily Awes Anderson
Phone: 612-624-0999
Email: awes0005@umn.edu
Fax: 612-625-2174
Summary
My main clinical interests are cystic fibrosis (CF) and lung transplantation. I developed and direct the University of Minnesota Adult CF Program and am Director of our CF Center. In addition to CF, I am interested in the management of other bronchiectatic lung disease including Primary Ciliary Dyskinesia. I am involved in the pre-transplant evaluation and post-transplant management of patients referred for lung transplantation for both CF and other end-stage lung disease. My involvement in lung transplantation has led me to develop expertise in interventional bronchoscopy for both transplant-related and non-transplant airway disease. I am experienced in balloon dilation, and stent placement. In the in-patient arena I mainly focus on CF and lung transplantation, but also participate in general pulmonary consultation and all aspects of intensive care management. In addition to my direct patient care responsibilities, I participate actively in continuous clinical quality improvement activities in the Adult CF Program.
Research Summary
I have served as site Primary Investigator for a number of phase II and III trials for new medications for CF patients, including VX-770 and Denfosol. I have participated as a co-investigator for numerous other phase I-III trials for new CF and transplant medications as well.I have also participated as a primary or co-investigator for a number of investigator-initiated clinical studies. I am an active participant in a number of collaborative studies at the University of MN CF Center, related to cystic fibrosis and lung transplantation.
Clinical Summary
- Cystic fibrosis
- Lung transplantation
- Primary ciliary dyskinesia
- Bronchiectasis
- Interventional bronchoscopy
Education
Honors and Recognition
Bio
Administrator Info
Name: Roberta Beach
Email: rmbeach@umphysicians.umn.edu
Mail: 420 Delaware Street SE
MMC 508 Mayo
8508A (Campus Delivery Code)
Minneapolis, MN 55455
Summary
Daniel Duprez, MD, PhD was born in Belgium and received his MD and PhD degree at the University of Ghent in Belgium. He completed his medicine residency and cardiology fellowship at the University of Ghent, followed by a fellowship at Mayo Clinic, Rochester, MN. He obtained a Hospital Management degree at the Catholic University of Leuven, Belgium. He was Professor Medicine/Cardiology at the University Ghent Belgium. In 2002, he joined the University of Minnesota, where he is tenured Professor of Medicine/Cardiology, holder of the Donald and Patricia Garofalo Chair in Preventive Cardiology at the School of Medicine and Adjunct Professor of Epidemiology and Community Health at the School of Public Health.My clinic research is focused on early detection and treatment of cardiovascular disease, arterial stiffness/elasticity in health and disease, lipids and novel biomarkers of inflammation and thrombosis in different ethnicities (CARDIA study, MESA study population, HIV population). I have received multiple NIH grants in these domains. I am a clinical trialist and I have studied dozens of new compounds of clinical trials in phase II, III and IV and have served on many study committees regarding design and adjudication events committees of international outcome trials.I serve at different NIH scientific grant review committees in USA, at different scientific grant committees of several European countries (Belgium, UK, France, Italy, Czech Republic, Poland), South Africa, United Arabic Emirates, Singapore. I have been involved in international education programs with the European Union regarding review and development.As a clinician, I focus on early detection of cardiovascular disease, lipid abnormalities, hypertension, and prevention of established atherosclerotic cardiovascular disease.
Research Summary
Mathematical modeling of the arterial system, arterial stiffness, diagnostic and predictive value in clinical setting and epidemiological study cohorts (MESA study cohort- NIH grants) Role of ethnicity on the predictive value of phenotypes of cardiovascular structure and function, biomarkers of inflammation, coagulation, lipoprotein particles and cardiovascular outcome (MESA study and CARDIA study – NIH grants) Lipoproteins, arterial stiffness, inflammatory markers in HIV patients and target organ damage and outcome (SMART and START – NIH grants) Clinical mechanistic, pharmacodynamics and outcome studies with new therapeutic compounds in the area of hypercholesterolemia/hypertriglyceridemia, hypertension, primary and secondary cardiovascular prevention (phase II, III, IV) Predictive value of cardiovascular biostatistical vs phenotype parameters in the Rasmussen Center for Cardiovascular Disease Prevention (philanthropy)
Teaching Summary
- Lipid abnormalities
- Arterial Mechanics
- Arterial stiffness
- Ventriculo-vascular coupling
- Structural and functional cardiovascular abnormalities
- Study cohorts
- Clinical trials and design (Phase II, III, IV)
- Cardiovascular Disease
- Epidemiology and Public Health
Honors and Recognition
Professional Memberships
Languages
Selected Publications
Bio
Administrator Info
Name: Karen Fitz
Phone: 612-626-5906
Email: fitz0355@umn.edu
Summary
Dr. Craig Eckfeldt graduated from the University of Minnesota's Combined M.D./Ph.D. Program with a Ph.D. in Microbiology, Immunology and Cancer Biology (advisor: Catherine Verfaillie, M.D.) in 2005 and an M.D. in Internal Medicine in 2007. He received the Minnesota Medical Foundation J. Thomas Livermore Award in 2005 and was elected to Alpha Omega Alpha Honor Society in 2006. Dr. Eckfeldt is a graduate of the fellowship program in Hematology, Oncology and Transplantation at the University of Minnesota. He joined the Hematology, Oncology and Transplantation faculty in July 2013.
Research Summary
Developing novel targeted and immune therapy approaches for acute myeloid leukemia (AML). The goal of the research in our lab is to investigate the genetics and signaling pathways that drive acute myeloid leukemia (AML) to provide a foundation for the development of novel targeted and immune treatment approaches for AML. Our research is focused on identifying the critical pathways that drive AML growth and survival, evaluating the effects of targeted therapies in preclinical cancer models, and studying how targeted therapies influence the susceptibility of cancer cells to immune therapies such as Natural Killer (NK) cell immunotherapy, an area of institutional expertise. We utilize cutting edge molecular genetic techniques and genetically engineered and humanized mouse models including patient-derived AML xenografts for our preclinical studies. Ultimately, we aim to translate our findings to human clinical trials for cancer patients.
Clinical Summary
Blood Cancers; Acute Leukemia; AML; MDS; Novel Therapies
Education
Honors and Recognition
Professional Memberships
Bio
Administrator Info
Name: Nephrology Division
Phone: 612-624-9444
Email: renaldiv@umn.edu
Fax: 612-626-3840
Summary
Dr. El-Rifai earned her medical degree from the American University of Beirut. She completed her internal medicine residency, nephrology fellowship at University Hospitals of Cleveland, Case Western Reserve University and transplant nephrology fellowship at Northwestern Memorial Hospital. She then joined the Nephrology faculty at MetroHealth, Case Western Reserve University where she initiated an outpatient transplant and glomerulonephritis clinic. She also served as the medical director of the Outpatient Hemodialysis unit at MetroHealth.
Research Summary
- Recurrent Glomerulonephritis Post Transplant
- Immune Monitoring in Kidney/Pancreas Transplant
- Genetic Testing in Kidney Transplantation
- BK Nephropathy
Teaching Summary
-
Immunosuppression
-
Transplant Immunobiology
Clinical Summary
- BK Nephropathy
- Pregnancy in Kidney Transplant
- Malignancy after Kidney Transplant
Education
Honors and Recognition
Professional Memberships
Bio
Administrator Info
Name: Nephrology
Phone: 612-624-9444
Email: renaldiv@umn.edu
Fax: 612-626-3840
Mail: 717 Delaware Street SE
Suite 353
MMC 1932
Minneapolis, MN 55414
Summary
Dr. Sarah Elfering has earned her medical degree from the University of Minnesota Medical School. She completed her Internal Medicine Residency at the Providence St. Vincent Medical Center in Portland, Oregon and returned to the University of Minnesota Medical School for her Nephrology Fellowship. Dr. Elfering's clinical and research interests include medical management of kidney stones, chronic kidney disease and dialysis.
Research Summary
- Medical Management of Kidney Stones
- Chronic Kidney Disease
- Dialysis
- Genetic Kidney Diseases
Research Projects
- Contamination Resistant Interconnection for Reducing Peritoneal Dialysis Associated Peritonitis (2020-2021)
- I-Corps: Sterile Connection Interface Technology (2019-2020)
- Reducing infection risks on in pediatric patients on peritoneal dialysis (2019)
Clinical Summary
- Medical Management of Kidney Stones
- Chronic Kidney Disease
- Dialysis
- Internal Medicine
- Genetic Kidney Diseases
Education
Honors and Recognition
Professional Memberships
Selected Publications
Bio
Administrator Info
Name: Drew Keup
Email: keupx013@umn.edu
Summary
Dr. Elfishawi graduated from Kasr-Alainy School of Medicine - Cairo University where he also completed rheumatology training and Masters' degree in rheumatology in 2016. He completed internal medicine residency at Icahn School of Medicine at Mount Sinai - Queens Hospital Center program, New York City, NY where he also served as chief resident and as a member in the Mount Sinai Graduate Medical Education committee. He completed rheumatology fellowship as well as VCRC-Vasculitis Foundation fellowship at the Mayo Clinic - Rochester, MN. He served as a member at the American College of Rheumatology (ACR) Fellows-in-Training (FIT) subcommittee responsible for planning educational sessions by the ACR for rheumatology fellows.
His Clinical and research interest include Vasculitis, Aortitis, IgG4-related disease as well as Gout and Musculoskeletal ultrasound-guided procedures.
Research Summary
- Large vessel vasculitis
- Aortitis
- ANCA-associated vasculitis
- Gout
Teaching Summary
- Vasculitis lectures for fellows and residents
- Musculoskeletal ultrasound guided procedures
Clinical Summary
- Vasculitis
- Non-infectious Aortitis
- Gout
- Ultrasound guided musculoskeletal injections
- IgG4 related disease
Education
Fellowships, Residencies, and Visiting Engagements
Honors and Recognition
Professional Memberships
Bio
Administrator Info
Name: Kathy Vang
Email: vang3630@umn.edu
Summary
Dr. Elliott completed medical school at the University of Texas at Houston followed by Internal Medicine Residency, a chief year, General Cardiology fellowship then time on a T32 research fellowship at the University of Pittsburgh Medical Center. After Cardiology fellowship Dr. Elliott spent a year on faculty in the Division of Cardiology followed by additional fellowship training in Critical Care Medicine. She will be joining the team at the University of Minneapolis primarily as a cardiac intensivist with special interest in Cardiac Critical Care fellowship training/education, ECPR and research in post ICU follow-up care.
Research Summary
- Post ICU follow-up care clinics evaluation and efficacy
- Outcomes-based research of advanced mechanical and chemical hemodynamic support
- Evaluation of racial disparities in end-of-life care
Clinical Summary
- Cardiac Critical Care
- post ICU out-patient follow up care
- ECPR
Education
Honors and Recognition
Professional Memberships
Bio
Administrator Info
Name: Becca Johnson
Phone: 612-624-9996
Fax: 612-625-4410
Email: joh07913@umn.edu
Mail: Mayo Memorial Building, MMC 250, 420 Delaware Street S.E., Minneapolis, MN 55455
Summary
Dr. Enriquez is an Assistant Professor of Medicine in the Division of Infectious Diseases and International Medicine at the University of Minnesota. He graduated with a medical degree from Sidney Kimmel Medical College of Thomas Jefferson University in Philadelphia where he then completed an Internal Medicine residency training program at Thomas Jefferson University Hospital. He continued his medical training in Chicago where he graduated from an Infectious Diseases fellowship at the University of Chicago Medicine followed by an advanced ID fellowship in Global Health, Travel, & Tropical Medicine at the University of Chicago Medicine. In addition, he has attended the Gorgas Diploma Course in Tropical Medicine in Lima, Peru through the Alexander von Humboldt Tropical Medicine Institute. His interests include global health, tropical medicine, travel medicine, tuberculosis management, HIV care, zoonotic infections, and general ID. He is fluent in English and is proficient in Spanish.
Research Summary
- Tropical medicine
- Medical education
- Tuberculosis
- Global health
- HIV care
- Zoonotic infections
Teaching Summary
-
Adult Infectious Diseases
Clinical Summary
- Travel and Tropical Medicine
- HIV management
- Tuberculosis management
- Endemic mycoses
- Zoonotic infections
- General Infectious Diseases
Education
Fellowships, Residencies, and Visiting Engagements
Languages
Bio
Administrator Info
Name: Admin
Phone: 612-624-9996
Fax: 612-625-4410
Email: idimdivision@umn.edu
Mail: Mayo Memorial Building, MMC 250, 420 Delaware Street S.E., Minneapolis, MN 55455
Summary
Dr Edwin Erayil grew up in India and completed medical school at St. John's National Academy of Health Sciences, Bangalore. She pursued a Master Thesis in Public Health at Umea University, Sweden, before moving to the United States for her residency training In Internal Medicine at Loyola Medicine MacNeal Hospital. She then completed her fellowship in Infectious Diseases at University of Minnesota Medical School, where she served as the Chief Fellow in her final year of training. Her primary research focus is on Candidemia and resistant Candida infections, including molecular epidemiology of these infections. Dr. Edwin Erayil takes care of patients with general infectious diseases and HIV in her clinical practice, and is particularly interested in the care of vulnerable populations. Her academic interests also include social determinants of health and Narrative Medicine.
Research Summary
Molecular Epidemiology of Candidemia and resistant Candida Infections Social Determinants of Health Narrative Medicine Antimicrobial Stewardship
Clinical Summary
Infections in Vulnerable Populations, Orthopedic Infections; Recurrent Urinary Tract Infections; Tickborne Illnesses; HIV
Education
Fellowships, Residencies, and Visiting Engagements
Honors and Recognition
Professional Memberships
Bio
Administrator Info
Name: Linsey Roschen
Email: rosch053@umn.edu
Fax: 612-625-6919
Summary
Dr. Andrea Espejo Freire is an oncologist specializing in the care of patients with sarcomas and other rare tumors. Dr. Espejo Freire received her medical degree from the Universidad San Francisco de Quito, Ecuador. She completed her residency in internal medicine and fellowship in hematology and oncology at the University of Miami/Jackson Memorial Hospital. Dr. Espejo Freire has contributed to describing the genomic biology of angiosarcoma, leiomyosarcoma, and synovial sarcoma, among other tumors. Her goal is to translate molecular findings into new targeted therapies for patients living with these aggressive tumors. Dr. Espejo Freire has also studied the efficacy of different treatment regimens for patients with bone sarcomas and angiosarcomas. This is important as therapies for sarcomas are not well established and the toxicities are significant. One of Dr. Espejo Freire's major research interests is the study of the tumor microenvironment for the purpose of developing strategies to overcome tumor resistance to immunotherapy.
Research Summary
- Genomics of angiosarcomas
- Tumor microenvironment modulation
- Immunotherapy
Teaching Summary
-
Clinical Management of patients with sarcomas
-
Immuno-oncology
-
Molecular pathways in sarcomas
Clinical Summary
-
Sarcomas
-
Angiosarcoma
-
Immunotherapy
Education
Honors and Recognition
Professional Memberships
Bio
Administrator Info
Name: Jill Charles
Phone: 612-624-0468
Email: jcharles@umn.edu
Fax: 612-626-6782
Mail: 717 Delaware Street SE
Suite 166
Minneapolis, MN 55414
Summary
Dr. Susan Everson-Rose, PhD, MS, MPH, FABMR, FAPS, is a tenured Professor in the Department of Medicine where she also serves as Associate Director for Research in the Division of General Internal Medicine. She also is Associate Director of the Program in Health Disparities Research, and Director of the Health Equity Leadership and Mentoring (HELM) program, which provides career development support and leadership training for early-stage investigators doing health equity work and/or identifying from a group under-represented in medicine and science. She is trained in psychophysiology, health disparities, and cardiovascular and social epidemiology and has over 30 years of experience as an NIH-funded investigator. The overarching goal of her research, which is guided by a Social and Structural Determinants of Health (SSDOH) framework, is to understand how lived experiences influence the patterning of health and disease across diverse patient populations and community samples. Her work has shown how stress, distress, emotions, personality, behavioral, social and economic factors contribute to morbidity and mortality due to cardiovascular diseases and related conditions, greater cognitive decline, cancer-related behavioral and lifestyle risk factors, and worse health outcomes overall. Her most recent work focuses on evidence-based stress-management, and mindfulness-based interventions that can be used to effectively manage chronic disease conditions and promote healthier lifestyles in diverse settings. Dr. Everson-Rose has published extensively (>150 peer-reviewed manuscripts that collectively have been cited in the literature >21,000 times) and is nationally and internationally recognized for her expertise in psychosocial factors in chronic disease.
Education
Honors and Recognition
Selected Publications
Bio
Administrator Info
Name: Jill Lane
Email: jdlane@umn.edu
Summary
My scholarship focuses on communication in healthcare. I have taught at a variety of levels. My NIH funding has mostly focused on communication processes and outcomes after newborn genetic screening. My clinical expertise is primary care (and some consultation) for complex patients, especially those with genetic and functional conditions.
Research Summary
- Communication in healthcare services
- Newborn screening
Teaching Summary
- Communication
- Medical humanities/film (implications for clinical practice and ethics)
- Pharmacogenetics
- Scholarly activities for medical students and residents.
Clinical Summary
- Primary and coordinating care for complex patients, especially adolescents and young adults with genetic problems and special needs
- Pharmacogenetics
- Autonomic dysfunction
Education
Fellowships, Residencies, and Visiting Engagements
Honors and Recognition
Professional Memberships
Selected Publications
Bio
Administrator Info
Name: Rheumatology
Email: rheumadm@umn.edu
Mail: 420 Delaware Street SE
MMC 108
Minneapolis, MN 55455
Summary
Dr. Parastoo Fazeli is an Associate Professor of Medicine in the Division of Rheumatology at University of Minnesota. She is the Director of the Lupus Clinic, the Program Director for Adult Rheumatology Fellowship Program and the Rheumatology Course Director for University of Minnesota Medical school. She also is part of Minnesota Multidisciplinary Vasculitis Program at University of Minnesota.
She currently serves as the president for the Rheumatology Association of Minnesota and the Dakotas (RA-MD) meeting.
Dr. Fazeli obtained her medical degree at Mashhad University of Medical Sciences. She completed her Internal Medicine Residency at St. Agnes Hospital; one of The Johns Hopkins affiliated hospitals, where she served as a chief resident. She did her Lupus Fellowship at Johns Hopkins University and fellowship training in Rheumatology at the University of Virginia. She served as a chief fellow during her second year of fellowship.
She is the recipient of University of Minnesota Educational Excellence Award and Clinical Excellence Award, and has been listed as "Top Doctors" in Minnesota Monthly Magazine.
Research Summary
Dr. Fazeli has clinical and research interest in systemic lupus erythematosus (SLE) and lupus in pregnancy.
Clinical Summary
- Lupus
- Lupus in pregnancy
- Anti-phospholipid syndrome (APS)
- APS in pregnancy
- Sjogren's syndrome
Education
Professional Memberships
Bio
Administrator Info
Name: Amirah Muwahid
Email: muwah012@umn.edu
Summary
Dr. Felices received his Ph.D. in immunology from UMASS Medical School in 2008, where his research focused on innate and adaptive immune subsets. He then pursued an industry postdoctoral fellowship at Novartis Institutes for BioMedical Research, in Cambridge, MA, in the Developmental and Molecular Pathways group where he studied signaling pathways involved in liver injury and tumorigenesis. In 2011 he joined the University of Minnesota as a T32 postdoctoral fellow in the HOT division, focusing his research on Natural Killer (NK) cell biology, prior to becoming an assistant professor. Dr. Felices' group focuses on methodologies to improve NK cell immunotherapy, with a particular focus on cytokine signaling and development NK specific biologics. In recent years Dr. Felices has been dedicating most of his effort on a Tri-specific Killer Engager (TriKE) platform to target NK cells to tumors while providing a cytokine signal.
Research Summary
- NK cell biology (development, survival, and function)
- Cancer immunology
- Signal transduction
- Immune metabolism
- Immunotherapy Biologic
- Cytokine signaling
- Biologic design/production (bi- and tri-specifics)
Professional Memberships
Selected Publications
Bio
Administrator Info
Name: Drew Keup
Lab Phone: 612-624-6149
Email: keupx013@umn.edu
Mail: Director, Center for Autoimmune Disease Research
2101 6th ST SE, 3-146 WMBB
Minneapolis, MN 55455
Summary
Dr. Brian Fife is a Professor of Medicine within the Division of Rheumatic and Autoimmune Diseases at the University of Minnesota Medical School. He joined the division in February 2008. He is also a member of the interdisciplinary Center for Immunology and Director of the Center for Autoimmune Disease Research (CADRe). Within the Center for Immunology, Dr. Fife also serves as the Imaging Core Director using advanced imaging techniques in his own research program. In December 2001, Dr. Fife graduated from Northwestern University Medical School. It is there that he initiated his research interests in autoimmune mediated diseases. Following graduation, Dr. Fife joined the Diabetes Center in the Department of Medicine at the University of California at San Francisco for postdoctoral research with Dr. Jeffrey Bluestone. The major focus of his research program is the restoration of immunological self tolerance for treatment of autoimmunity. Dr. Fife is interested in understanding immuological tolerance during Type 1 diabetes and focuses his efforts on understanding checkpoint blockade and the role for inhibitory pathways such as CTLA-4 and PD-1. This work has extending into tumor immunology and understanding the mechanisms involved in checkpoint blockade. Most recently his work has focused on chimeric antigen receptor T cells (CAR T cells) for novel treatment approaches for autoimmunity.
Research Summary
- Autoimmunity
- Type 1 diabetes
- Regulatory T cells
- CAR T cells
- CAR Tregs
- Checkpoint immunotherapy
- PD-1
- PD-L1
- T cell tolerance and transplantation tolerance
Research being conducted by the Fife Laboratory:
Research in our lab is focused on understanding the fundamental mechanisms that regulate T lymphocytes during autoimmune disease such as Type 1 diabetes mellitus (T1DM). T1DM is an autoimmune disorder resulting from the T cell mediated destruction of the insulin producing cells within the pancreas. At the root of autoimmunity lies the most important aspect of immune regulation, the ability to discriminate between self and non-self. This highly selective response is characterized by a complicated set of mechanisms which regulate T lymphocyte activity. Autoimmunity results when these mechanisms fail. We have generated a powerful treatment protocol to selectively target autoreactive cells. Using this type of approach allows us to re-educate the immune system to selectively silence destructive immune responses. Thus in effect, restore a state of self-tolerance and prevent further tissue destruction. We have identified two key regulatory pathways that control diabetes and promote tolerance, Cytotoxic T lymphocyte antigen-4 (CTLA-4) and Programmed Death-1 (PD-1). We have shown that these pathways control both anergy induction and long term maintenance of tolerance. Using our tolerance protocol will allow us to determine the precise roles of these negative regulatory pathways at different stages during disease pathogenesis to control immunity and enhance tolerance. More recent studies are focused on T1DM therapies including the use of regulatory T cells or Tregs. In addition to this approach we several projects focused on the generate of chimeric antigen receptor T cells or CAR T cells. These projects will determine if antigen-specific approaches will be a viable therapy for autoimmunity.
Education
Honors and Recognition
Bio
Administrator Info
Name: Becca Johnson
Phone: 612-624-9996
Fax: 612-625-4410
Email: joh07913@umn.edu
Mail: Mayo Memorial Building, MMC 250, 420 Delaware Street S.E., Minneapolis, MN 55455
Summary
Dr. Fontana is an assistant professor in the Division of Infectious Diseases. Her clinical and research interests are focused in the immunocompromised host including solid organ and bone marrow transplant recipients as well as patients with hematologic malignancies. Dr. Fontana also has interests in leadership development and medical education.
Research Summary
- HIV in solid organ transplant
- Bacterial and Fungal infections in transplant recipients and the immunocompromised host
- Preventive care in prevention of infections in the immunocompromised host
Teaching Summary
-
Transplant ID Fellowship Program Director
-
American Society of Transplant Education Subgroup
Clinical Summary
-
Clinical Excellence Honoree 2023, University of Minnesota Physicians
-
Infectious Diseases Service Line Medical Director
-
Clinical focus in transplant infectious diseases, HIV, and the immunocompromised host
Education
Fellowships, Residencies, and Visiting Engagements
Professional Memberships
Bio
Dr. Freeman is a Professor of Medicine in the GI Division and serves as the Associate Program Director of the Advanced Pancreaticobiliary Endoscopy Fellowship at the University of Minnesota. He has trained numerous advanced endoscopists, many of whom have gone on to leadership positions, and has led and participated in numerous courses in Advanced Endoscopy for the ASGE. He was the lead author on three educational DVD's for the ASGE including techniques for biliary access during ERCP, endoscopic therapy of pancreatic disease, and on interventions for necrotizing pancreatitis. He received the Master of Endoscopy Award by the American Society for Gastrointestinal Endoscopy in 2012, served as President of the American Pancreatic Association in 2013, then received their lifetime achievement award in 2018, was honored as a Master of the American College of Gastroenterology in 2019 and as Master of the American Society for Gastrointestinal Endoscopy in 2020 . Dr Freeman's main clinical and research interests involve pancreatic and biliary disorders, with a focus on interventional endoscopy. Dr. Freeman has published over 30 textbook chapters, and 250 peer reviewed articles, including several index papers for which he was the principal author: a multicenter study on ERCP complications in the New England Journal of Medicine, a multivariable model for prediction of post ERCP pancreatitis in Gastrointestinal Endoscopy, guidelines for the management of acute pancreatitis in the American Journal of Gastroenterology, and a consensus paper and a systematic review on interventions for necrotizing pancreatitis in the Pancreas, and recently in Gastroenterology . Other research areas include drainage of malignant hilar obstruction and treatment of sphincter of Oddi dysfunction, for which he was a contributor to a recently completed multicenter NIH funded randomized trial. Major directions of his clinical interests and research at present include management of severe acute pancreatitis, recurrent acute pancreatitis, pancreaticobiliary cancers, and diagnosis and management of chronic pancreatitis.
Research Summary
Research interests involve pancreatic and biliary disorders, with a focus on interventional endoscopy. Dr. Freeman has published over 30 textbook chapters, and 250 peer reviewed articles, including several index papers for which he was the principal author: a multicenter study on ERCP complications in the New England Journal of Medicine, a multivariable model for prediction of post ERCP pancreatitis in Gastrointestinal Endoscopy, guidelines for the management of acute pancreatitis in the American Journal of Gastroenterology, and a consensus paper and a systematic review on interventions for necrotizing pancreatitis in the journals Pancreas, and recently in Gastroenterology . Other research areas include drainage of malignant hilar obstruction and treatment of sphincter of Oddi dysfunction, for which he was a contributor to a recently completed multicenter NIH funded randomized trial. Major directions of his clinical interests and research at present include management of severe acute pancreatitis, recurrent acute pancreatitis, pancreaticobiliary cancers, and diagnosis and management of chronic pancreatitis.
Teaching Summary
Dr. Freeman was the past chief of the Division of Gastroenterology, Hepatology, and Nutrition, was medical director of the program for total pancreatectomy and islet autotransplantation until 2021, and director of the advanced pancreaticobiliary endoscopy fellowship at the University of Minnesota until 2021. He has trained numerous advanced endoscopists, many of whom have gone on to leadership positions around the United States and abroad, and has led and participated in numerous courses around the world.
Clinical Summary
Clinical interests include management of severe acute pancreatitis, recurrent acute pancreatitis, pancreaticobiliary cancers, and diagnosis and management of chronic pancreatitis. Dr. Freeman sees patients at M Health Fairview Clinics and Surgery Center - Minneapolis and M Health Fairview University of Minnesota Medical Center, and performs procedures at those locations and at Masonic Childrens Hospital.
Education
Fellowships, Residencies, and Visiting Engagements
Honors and Recognition
Professional Memberships
Selected Publications
Contact
Administrative Contact
GI Division
Phone: 612-625-8999
Email: gidivision@umn.edu
Mail: 420 Delaware Street SE, MMC 36, Minneapolis, MN 55455
Education
Fellowships, Residencies, and Visiting Engagements
Licensures and Certifications
Honors and Recognition
Professional Memberships
Contact
Address
420 Delaware Street, SE, MMC 292, Minneapolis, MN 55455Bio
Administrator Info
Name: Ms. J. Knapp
Phone: 612-626-1422
Fax: 612-625-6919
Email: jknapp@umn.edu
Mail: 420 Delaware Street SE, MMC 480, Minneapolis, MN 55455
Summary
Dr. Fujioka is a Medical Oncologist specializing in thoracic and head/neck malignancies. Her research is focused on developing food-based chemoprevention against tobacco and environmental carcinogens. Dr. Fujioka also acts as site Principal Investigator for cancer therapy clinical trials. She joined the faculty in 2011 after completing all of her training at the University of Minnesota.
Research Summary
- Lung cancer chemoprevention
- Tobacco carcinogens and carcinogenesis
- Food-based chemoprevention of tobacco-related lung cancer
Clinical Summary
- Lung Cancer
- Lung Cancer Chemoprevention
- Head and Neck Cancer
Education
Honors and Recognition
Professional Memberships
Bio
Administrator Info
Name: Ashley Fuchs
Phone: 612-624-0999
Email: fuchs@umn.edu
Fax: 612-625-2174
Summary
I am a general pulmonologist and critical care physician with a particular clinical interest in diseases that affect the airways of the lungs such as asthma and chronic obstructive pulmonary disease. My current research interest involves how oral health may affect patients with chronic lung disease. In addition to my outpatient lung clinic, I work in the medical intensive care unit where I am involved in medical education and serve as the critical care site director for the medical school.
Research Summary
- Dental Health in Lung Disease
- Lung Mechanics in Pulmonary Fibrosis
Clinical Summary
- Asthma
- Alpha-1 Antitrypsin Deficiency
- Acute Respiratory Distress Syndrome (ARDS)
- Cardiopulmonary Physiology
- Chronic Obstructive Pulmonary Disease (COPD)
- Non-cystic fibrosis bronchiectasis
- Respiratory Failure
- Sarcoidosis
- Sepsis
Education
Honors and Recognition
Professional Memberships
Bio
Administrator Info
Name: Becca Johnson
Phone: 612-624-9996
Fax: 612-625-4410
Email: joh07913@umn.edu
Mail: Mayo Memorial Building, MMC 250, 420 Delaware Street S.E., Minneapolis, MN 55455
Summary
Dr. Galdys graduated from the UMN Medical School. She completed a combined residency in Internal Medicine and Pediatrics followed by a fellowship in Infectious Diseases at the University of Pittsburgh Medical Center. Dr. Galdys serves as the Assistant Medical Director of Infection Prevention and as Assistant Hospital Epidemiologist. Her research interests include the use of molecular techniques to detect transmission patterns of bacteria in healthcare settings. In addition to her Infection Prevention roles, Dr. Galdys has a clinical practice that consists of caring for general inpatient and outpatient infectious diseases. Her areas of clinical interest include Clostridioides difficile infection and orthopedic infections.
Research Summary
- Molecular epidemiology of healthcare-associated pathogens
- Infection reporting and accountability
- Outbreak Detection Hospital preparedness for emerging pathogens
Clinical Summary
- C. difficile infection
- Orthopedic Infections
Education
Fellowships, Residencies, and Visiting Engagements
Honors and Recognition
Selected Publications
Bio
Administrator Info
Name: Lisa Moe
Email: seif0046@umn.edu
Mail: Cancer & Cardiovascular Research Building
2231 6th St SE, 1st floor Mailroom CCRB
Minneapolis, MN 55455
Summary
The Garry lab has two major areas of focus. The first area of focus is the neural control of cardiovascular responses to exercise. Specifically, the lab focuses on the Exercise Pressor Reflex which is a reflex activated by skeletal muscle contraction. The Garry lab has developed novel rodent models (rat and mouse) to explore the mechanisms that mediate this reflex in both physiological and pathological states. Abnormal function of this reflex occurs in a variety of diseases such as heart failure, hypertension, and diabetes and extreme abnormalities serves as a poor prognostic indicator. The goal of the lab is to identify specific mechanisms that underlie the abnormal reflex in various disease such that normalization of the reflex can be targeted with novel therapies. The second area of focus for the Garry lab is the generation of humanized organs for 1) novel human research models and 2) transplantation purposes. To that end, we have generated several models in which pigs develop humanized organs. Specifically, we have developed pigs with human skeletal muscle and pigs with human blood vessels and blood. These models will be used to generate unique research models and even allow for a new form of clinical trial without human risk. Additionally, we are developing organs for human transplantation purposes that will treat injury based deficits such as volumetric muscle loss. Moreover, these technologies can treat peripheral artery disease and can help to meet the staggering demand for human blood and platelets.Come work with us! Visit https://med.umn.edu/lhi/about/jobs to see open positions in the Mary Garry lab.
Research Summary
- Neural control of cardiovascular responses to exercise
- Generation of humanized organs for 1) novel human research models and 2) transplantation purposes
Professional Memberships
Bio
Administrator Info
Name: Lisa Moe
Email: seif0046@umn.edu
Mail: Lillehei Heart Institute
2231 6th Street SE
1st floor Mailroom CCRB
Minneapolis, Minnesota 55455
Research Summary
Regenerative medicine, Cardiogenesis, and Stem-Cell BiologyDan's laboratory has a long-standing interest in regenerative and stem cell biology with a focus on the heart and skeletal muscle. In their studies of the heart and skeletal muscle, the Garry laboratory utilizes an array of technologies including gene disruption strategies, transgenesis, single cell genome analysis, gene editing (TALEN and CRISPR technologies), inducible ES/EB model systems, hiPSC technologies, FACS and other cellular, biochemical and molecular biological techniques. In addition, their use of lower organisms such as zebrafish and newt, which are highly regenerative model systems have successfully uncovered critical regenerative factors. Human iPSCs are another important model for cardiovascular disease investigation for the lab. Using these technologies, the Garry lab was among the first to discover the molecular markers of stem cell populations that regulate critical networks during heart and skeletal muscle development and regeneration. For example, their studies have uncovered novel Ets and Forkhead transcription factors, microRNAs and signaling pathways that direct fate determination of stem cell populations. The manipulation of these pathways using chemical genetics and molecular technologies has provided a platform focused on rebuilding and repairing the injured heart and skeletal muscle. Care Philosophy My philosophy is to provide outstanding comprehensive care to patients with cardiovascular disease, including a number of emerging technologies available at the University of Minnesota Medical Center-Fairview. My practice combines state-of-the-art therapies, compassion, and effective communication, creating a working partnership that results (overall) in high quality of life for my patients.
Clinical Summary
General cardiology; Advanced heart failure; Orthotopic heart transplant
Education
Honors and Recognition
Professional Memberships
Selected Publications
Grants and Patents
Patents
Bio
Sophie Gladding, PhD, is the Director of Educational Research and Development in the Department of Medicine. After completing an undergraduate degree at the University of Michigan, she received her Ph.D in Education from the University of Minnesota specializing in evaluation and assessment. Following graduate school, she completed a post-doctoral fellowship in medical education at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. She currently collaborates on educational research focusing on educational innovations and assessment and works with the educational leadership in the department in the development and implementation of learner assessments and program evaluation. She is also a member of the Division of Global Pediatrics in the Department of Pediatrics. The focus of her work in Global Pediatrics is in the development and evaluation of a competency-based curriculum in global child health.
Research Summary
Current and Recent Research Support Co-investigator, NIH Fogarty Grant, Northern/Pacific Global Health Research Fellows Training Consortium Co-investigator, Doris Duke Charitable Foundation, International Clinical Research Fellowships
Research Summary
I have a broad background in cardiovascular developmental biology, bioinformatics and computational biology, with specific training and expertise in database constructions, data analysis and algorithm development. I was trained in genetics and genomics, and have more than ten years of experience on bioinformatics and computational biology, including siRNA design, peptide array design, database construction and predicting development related genes. After I joined the Lillehei Heart Institute, I mainly focused on developing algorithms for single cell RNA-seq analysis including tools such as dpath (prediction of cell differentiation), TCM (visualization of temporal scRNA-seq data), DrImpute (imputing dropout events in the scRNA-seq data), DCLEAR (CRSPR/cas9-based single cell lineage reconstruction), and inferring gene regulatory networks from multi-dimensional omics- data. In addition, I have successfully collaborated with other investigators on the characterization of novel genes, microRNAs, long noncoding RNAs (lncRNAs) that have important functions in various biological processes. In addition, my laboratory has expertise using and analyzing large datasets focused on proteomics, metabolomics and transcriptomics. Combining the large scale genomic approaches with novel machine learning methods, we have recently deciphered the cell populations and defining pathways that are critical for hemato-endothelial development, cardiogenesis and cardiac regeneration. We will further employ these computational biological approaches to amplify and accelerate the research in heart development and cardiovascular disease.
Bio
Administrator Info
Name: DHM Admin Team
Email: dhmadmin@umn.edu
Phone Number: 612-624-0579
Fax Number: 612-624-3189
Summary
Jim Grace is a Med-Peds hospitalist with an interest in medical education, communication in the hospital, and clinical decision making.
Research Summary
Medical Education
Clinical Summary
Inpatient care of the adult and pediatric patient
Bio
Administrator Info
Name: Ms. J. Knapp
Phone: 612-626-1422
Fax: 612-625-6919
Email: jknapp@umn.edu
Mail: 420 Delaware Street SE, MMC 480, Minneapolis, MN 55455
Summary
Dr. Greeno received his M.D. in 1986 from Case Western Reserve University followed by internal medicine residency training and hematology subspecialty training at the University of Minnesota. He is board certified in Internal Medicine, Hematology, and Medical Oncology. He served as director of Hematology/Oncology at Hennepin County Medical Center prior to recruitment at the University of Minnesota. Dr. Greeno is the Medical Director of the Masonic Cancer Clinic at the University of Minnesota.He is also Executive Medical Director of University of Minnesota Cancer Care. He has conducted numerous human trials of cancer therapeutics, including an ongoing first in human study of Minnelide, a drug developed from a natural product at the University of Minnesota for pancreatic cancer.
Clinical Summary
GI malignacies, Colon cancer
Bio
Dr. Punita Grover is a medical oncologist specializing in blood and marrow transplantation for the treatment of hematologic malignancies. She completed her internal medicine residency at the University of Missouri-Kansas City; hematology oncology fellowship at the University of Cincinnati; and an advanced fellowship in bone marrow transplant and cellular therapy from Stanford University. Dr. Grover's clinical focus is treating acute leukemias and myeloid malignancies with allogeneic stem cell transplantation and cellular therapy. Her research interests are improving outcomes of allogeneic stem cell transplant through clinical trials using novel conditioning regimens, GVHD prophylaxis, maintenance and minimizing long term toxicities.
Research Summary
Oncologist
Teaching Summary
Clinical and Translational Research
Service Summary
American Society of Hematology; American Society of Transplantation and Cellular Therapy; American Society of Clinical Oncology
Clinical Summary
Allogeneic Stem Cell Transplantation; Cellular Therapy for Hematological Neoplasms
Contact
Administrative Contact
Name: Kris Blomquist
Email: krblomqu@umn.edu
Mail: 420 Delaware Street SE, MMC 480, Minneapolis, MN 55455
Bio
Administrator Info
Name: Admin
Phone: 612-624-9996
Email: idimdivision@umn.edu
Fax: 612-625-4410
Summary:
Dr. Gulleen is a physician-scientist trained in global health, epidemiology, implementation science, and immunocompromised infectious diseases. She has a particular interest in infections that occur in the oncology and hematopoietic stem cell transplant populations. Her research focuses on defining the microbiology of febrile illness among patients receiving cancer treatment in sub-Saharan Africa, with the goal of developing locally relevant infection management guidelines that will decrease infection-related mortality in this patient population. In addition, she uses implementation science to improve the diagnosis and management of infections and build antimicrobial stewardship programs for patients receiving cancer treatment in resource-limited settings. Dr. Gulleen is the PI of a Center for AIDS Research New Investigator Award investigating gastrointestinal colonization with multi-drug resistant bacteria among patients receiving cancer treatment in Uganda. She is also the PI of a study which uses principles of implementation science to identify and address barriers to rapid delivery of guideline-recommended antibiotics for Ugandan patients with neutropenic fever, funded by Fogarty International.
Dr. Gulleen is passionate about working with local clinicians and researchers to build collaborative, multi-disciplinary global health research programs that directly inform patient care. She has longstanding multidisciplinary clinical and research collaborations with colleagues at the Uganda Cancer Institute in Kampala, Uganda.
Expertise: Transplant Infectious Diseases; Tropical Medicine; Implementation Science; Epidemiology; Global Health
Research Summary
Microbiology, diagnosis, and management of febrile illness among patients with cancer; HIV-related opportunistic infections in oncology populations; Using implementation science to improve infection management in resource-limited settings; Antimicrobial stewardship in the immunocompromised host
Teaching Summary
Global Health; Implementation science; Antibiotic use and antimicrobial stewardship
Clinical Summary
Infectious diseases in the immunocompromised host; Antimicrobial stewardship; Clinical tropical medicine
Bio
Administrator Info
Name: Karen Fitz
Phone: 612-626-5906
Email: fitz0355@umn.edu
Summary
Dr. Gupta is a gastrointestinal oncologist, a symptom management enthusiast, and a health services researcher. His research specifically examines cancer care access and delivery, the costs of cancer care, and the hidden burdens imposed on and faced by people with cancer and their caregivers while receiving this care.
Research Summary
Dr. Gupta’s research is at the intersection of oncology, supportive care, and care delivery. His primary focus is identifying, understanding, and improving the ‘’hidden toxicities’’ of receiving cancer care. Many of the burdens of a cancer diagnosis and treatment on a patient and caregivers extend beyond the physical effects of the cancer itself. These include financial toxicity and caregiver burdens. The ultimate goal of this work is to improve the quality of life for people with cancer and their loved ones.
Teaching Summary
Gastrointestinal Cancer; Symptom Control; Supportive Care
Clinical Summary
gastrointestinal cancer (esophageal, stomach/gastric, gallbladder, biliary tract); cholangiocarcinoma; liver cancer; hepatocellular cancer; pancreatic cancer; neuroendocrine cancer; gastrointestinal stromal tumor; small bowel cancer; appendix cancer; colorectal cancer; anal cancer
Education
Professional Memberships
Bio
Dr. Sergey Gurevich is an interventional cardiologist with University of Minnesota Health. Dr. Gurevich competed his medical school at the Medical College of Wisconsin and his residency at New York Presbyterian-Weill Cornell Medical College. He joined the University of Minnesota Cardiovascular general fellowship in July of 2015 and subsequently completed his interventional training in 2018. Following his fellowship, he was asked to join the cardiovascular section at the University of Minnesota Medical School where his clinical focus has been primarily interventional coronary procedures including complex coronary intervention with mechanical circulatory support and chronic total occlusions.His research interests have focused on improving transcatheter therapies for structural heart disease including transcatheter aortic valve replacement and transcatheter mitral therapies. His translational research has been focused on implementation of emerging technologies into clinical practice. His work has been featured at several national and international conferences with a number of publications in peer-reviewed journals.
Research Summary
Dr. Gurevich's research focus is transcatheter therapies for structural heart disease
Clinical Summary
Cardiac CT, Coronary artery disease and intervention, Coronary artery disease (stable and unstable angina, myocardial, infarction), Coronary physiology, Hemodynamics, Interventional cardiology, Invasive hemodynamics, Mechanical circulatory support, Percutaneous closure of patent foramen ovale and atrial septal defect, Pulmonary artery hypertension, Structural heart disease, Transcatheter therapies, Valvular heart disease